Inpatient Order Entry for All IV and PO Fluoroquinolones

• Published literature supports the requirement of clinical indication at time of order entry to increase appropriate antimicrobial use.
• Indication at time of order entry is also recommended by the National Quality Partners (NPQ) and CDC.
• The FDA recommends reserving the use of fluoroquinolones for specific indications “…when patients have no alternative treatment options because of the risk of disabling and potentially serious adverse reactions (Eg, tendinitis and tendon rupture, peripheral neuropathy, CNS effects)”.
• ID Clinical Council endorses required indications for fluoroquinolone antibiotics to prompt provider and clinician assessment of antibiotic appropriateness.

Minor Consent

Indiana Minors may consent for pregnancy related services at the age of 16 as long as a reasonable effort to contact the minor’s parent or guardian has been initiated.

I-PASS at Riley

A handoff is considered a shift in responsibility from one person to another. This shift in responsibility can be about any subject, including but not limited to patient handoffs.

Policy Change: Use of Mother's Own Milk (MOM) with THC

Changes in the policy Lactation: Drugs of Abuse, Narcotics and use of Human Milk and the use of MOM with THC.

i-STAT Cartridges - Recall

On January 15, 2020, the sole source vendor for our i-STAT Point of Care (POC) testing system announced the conclusion
of an FDA evaluation, in which it was determined that three i-STAT "test modules" or cartridges (namely the CHEM8+,
CG4+, and G3+ cartridges) have lost FDA clearance due to an unapproved change in their design a several years ago.

BD PosiFlush Syringes

Providers are reporting issues using the BD PosiFlush Syringes accurately. BD PosiFlush syringes require its seal to be broken prior to use. This document contain instructions for breaking the seal for these syringes.

INSPECT

Providers must review the INSPECT report for each patient during every visit prior to prescribing an opioid or benzodiazepine.

C-Difficile Testing: Yes or No?